Susan Romanus
Net worth: 196 971 $ as of 30/05/2024
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ryuzo Takada | M | 78 | - | |
| Satoru Kimura | M | 66 | - | |
| Masahiko Ohtsuki | M | 64 | 14 years | |
| Toshiaki Tojo | M | 68 | 10 years | |
| Yoshifumi Nishikawa | M | 85 | - | |
| Robert Chen | M | - |
Taiho Oncology, Inc.
 Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | 1 years |
| Igor Gorbatchevsky | M | - | 5 years | |
| Jay Feingold | M | 67 | 4 years | |
| Francis Plat | M | 66 | 4 years | |
| Yuichiro Anzai | M | 77 | - | |
| Kunio Ishihara | M | 80 | 5 years | |
| Vojislav Vukovic | M | 57 |
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | 1 years |
| Hiroshi Hirabayashi | M | 84 | 5 years | |
| Jotaro Yabe | M | - | - | |
| Kunio Nihira | M | - | - | |
| Toru Kuroda | M | - | - | |
| Kiyoshi Morita | M | - | 3 years | |
| Stacey Bilinski | F | - |
Taiho Oncology, Inc.
Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | 7 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Japan | 15 | 83.33% |
| United States | 3 | 16.67% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Susan Romanus
- Personal Network
